Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1266 issues

How to Get Lutathera Covered by Blue Cross Blue Shield in California: Complete Forms, Portal & Appeals Guide

Answer Box: Getting Lutathera Approved by Blue Cross Blue Shield California Blue Cross Blue Shield California requires prior authorization for Lutathera (lutetium Lu-177 dotatate) as a medical benefit drug for somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Submit requests via your oncologist through the AuthAccel online system or contact Evolent at
7 min read

Work With Your Doctor to Get Cystadane (Betaine Anhydrous) Approved by Blue Cross Blue Shield in Washington: Complete Provider Collaboration Guide

Answer Box: Getting Cystadane Covered Through Provider Partnership Blue Cross Blue Shield requires prior authorization for Cystadane with genetic confirmation, vitamin therapy trials, and specialist involvement. Success depends on strong provider collaboration: gather genetic testing results and homocysteine labs (>100 μmol/L), document failed vitamin B6/B12/folate trials,
6 min read

How to Get Rezlidhia (olutasidenib) Covered by Blue Cross Blue Shield of Illinois: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Rezlidhia Covered by Blue Cross Blue Shield Illinois Blue Cross Blue Shield of Illinois (BCBSIL) requires prior authorization for Rezlidhia (olutasidenib) with documented IDH1 mutation testing and oncology monitoring plan. Submit through their provider portal with FDA-approved mutation results, treatment history, and differentiation syndrome monitoring protocol. BCBSIL
7 min read

How to Get Strimvelis Gene Therapy Covered by Blue Cross Blue Shield in Ohio: Complete Appeal Guide with Forms and Timelines

Answer Box: Getting Strimvelis Covered in Ohio Strimvelis (ADA-SCID gene therapy) requires prior authorization from Blue Cross Blue Shield in Ohio, with appeals following a structured timeline: internal review (30 days), second-level appeal if needed, then external review through Ohio's Independent Review Organization (180-day deadline from final denial)
7 min read